| Revenue, operating profit and segment analysis |
2 Revenue, operating profit and segment analysis [149]. Subscriptions – revenue comprises income derived from the periodic distribution or update of a product. Subscription revenue is generally invoiced in advance and recognised systematically over the period of the subscription. Recognition is either on a straight-line basis where the transaction involves the transfer of goods and services to the customer in a consistent manner over a specific period of time; or based on the value received by the customer where the goods and services are not delivered in a consistent manner Transactional – revenue is recognised when control of the product is passed to the customer or the service has been performed. For exhibitions, revenue primarily comprises income from exhibitors and attendees at exhibitions. Exhibition revenue is recognised on occurrence of the exhibition | Accounting policy The Group’s reported segments are based on the internal reporting structure and financial information provided to the Board. Adjusted operating profit is the key segmental profit measure used by the Group in assessing performance. Adjusted operating profit is reconciled to operating profit on page 148. Revenue arises from the provision of products and services under contracts with customers. In all cases, revenue is recognised to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services, and is recognised when the customer obtains control of the goods or service. Revenue is stated at the transaction price, which includes allowance for anticipated discounts and returns and excludes customer sales taxes and other amounts to be collected on behalf of third-parties. Where the goods or services promised within a contract are distinct, they are identified as separate performance obligations and are accounted for separately. Where separate performance obligations are identified, total revenue is allocated on the basis of relative standalone selling prices or management’s best estimate of relative value where standalone selling prices do not exist. Management estimates may include a cost-plus method or comparable product approach, but must be supported by objective evidence. A residual approach may be applied where it is not possible to derive a reliable management estimate for a specific component. Our subscription and exhibition related revenue streams generally require payment in advance of the service being provided. Payment terms offered to customers are in line with the standard in the markets and geographies we operate in, and contracts do not contain significant financing components. Contracts for our transactional electronic revenue streams generally have payments that vary with volume of usage. Other than that, our contracts do not involve variable consideration. Revenue is recognised for the various categories as follows: Subscriptions – revenue comprises income derived from the periodic distribution or update of a product. Subscription revenue is generally invoiced in advance and recognised systematically over the period of the subscription. Recognition is either on a straight-line basis where the transaction involves the transfer of goods and services to the customer in a consistent manner over a specific period of time; or based on the value received by the customer where the goods and services are not delivered in a consistent manner Transactional – revenue is recognised when control of the product is passed to the customer or the service has been performed. For exhibitions, revenue primarily comprises income from exhibitors and attendees at exhibitions. Exhibition revenue is recognised on occurrence of the exhibition |
2 Revenue, operating profit and segment analysis (continued) RELX is a global provider of information-based analytics and decision tools for professional and business customers. RELX operates in four business areas: Risk provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency; Scientific, Technical & Medical helps advance science and healthcare by combining high-quality, trusted scientific and medical information and data sets with innovative technologies to deliver critical insights that support better outcomes; Legal helps its customers improve decision-making, achieve better outcomes and increase productivity by providing tools that combine legal, regulatory and business information with powerful analytics; and Exhibitions combines industry expertise, digital tools, and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. RELX’s reported segments are based on the internal reporting structure and financial information provided to the Board, considered to be the Chief Operating Decision Maker. Prior period figures have been restated for the business area changes detailed in note 1, with print and print-related now a separate reported segment. | | | | | | | | | | | | | ANALYSIS BY REPORTED SEGMENT | | Revenue | | Adjusted operating profit | | | Restated 2023 GBPm | | Restated 2024 GBPm | | 2025 GBPm | | Restated 2023 GBPm | | Restated 2024 GBPm | | 2025 GBPm | Risk | | 3,224 | | 3,336 | | 3,485 | | 1,170 | | 1,233 | | 1,305 | Scientific, Technical & Medical | | 2,581 | | 2,624 | | 2,714 | | 940 | | 981 | | 1,035 | Legal | | 1,655 | | 1,718 | | 1,806 | | 360 | | 381 | | 415 | Exhibitions | | 1,115 | | 1,239 | | 1,186 | | 319 | | 398 | | 410 | Print & print-related activities | | 586 | | 517 | | 399 | | 253 | | 217 | | 185 | Sub-total | | 9,161 | | 9,434 | | 9,590 | | 3,042 | | 3,210 | | 3,350 | Unallocated central costs | | - | | - | | - | | (12) | | (11) | | (8) | Total | | 9,161 | | 9,434 | | 9,590 | | 3,030 | | 3,199 | | 3,342 |
The share of post-tax results of joint ventures and associates included in operating profit was £44m (2024: £43m; 2023: £46m). This comprised of profit/(loss) relating to Risk of £(1)m (2024: nil; 2023: £(1)m), Scientific, Technical & Medical £1m (2024: nil; 2023: nil), Legal £6m (2024: £7m; 2023: £10m) and Exhibitions £38m (2024: £36m; 2023: £37m). | | | | | | | | | | | | | 2023 | | Risk Restated GBPm | | Scientific, Technical & Medical Restated GBPm | | Legal Restated GBPm | | Exhibitions GBPm | | Print & print- related activities Restated GBPm | | Total Restated GBPm | Revenue by geographical market | | | | | | | | | | | | | North America | | 2,573 | | 1,108 | | 1,146 | | 217 | | 342 | | 5,386 | Europe* | | 423 | | 593 | | 334 | | 427 | | 131 | | 1,908 | Rest of world | | 228 | | 880 | | 175 | | 471 | | 113 | | 1,867 | Total revenue | | 3,224 | | 2,581 | | 1,655 | | 1,115 | | 586 | | 9,161 | | | | | | | | | | | | | | Revenue by format | | | | | | | | | | | | | Electronic | | 3,210 | | 2,574 | | 1,646 | | 85 | | - | | 7,515 | Face-to-face | | 14 | | 7 | | 9 | | 1,030 | | - | | 1,060 | Print | | - | | - | | - | | - | | 586 | | 586 | Total revenue | | 3,224 | | 2,581 | | 1,655 | | 1,115 | | 586 | | 9,161 | | | | | | | | | | | | | | Revenue by type | | | | | | | | | | | | | Subscriptions | | 1,330 | | 2,107 | | 1,363 | | - | | 176 | | 4,976 | Transactional | | 1,894 | | 474 | | 292 | | 1,115 | | 410 | | 4,185 | Total revenue | | 3,224 | | 2,581 | | 1,655 | | 1,115 | | 586 | | 9,161 |
2 Revenue, operating profit and segment analysis (continued) | | | | | | | | | | | | | 2024 | | Risk Restated GBPm | | Scientific, Technical & Medical Restated GBPm | | Legal Restated GBPm | | Exhibitions GBPm | | Print & print- related activities Restated GBPm | | Total Restated GBPm | Revenue by geographical market | | | | | | | | | | | | | North America | | 2,658 | | 1,126 | | 1,188 | | 231 | | 292 | | 5,495 | Europe* | | 439 | | 603 | | 351 | | 527 | | 105 | | 2,025 | Rest of world | | 239 | | 895 | | 179 | | 481 | | 120 | | 1,914 | Total revenue | | 3,336 | | 2,624 | | 1,718 | | 1,239 | | 517 | | 9,434 | | | | | | | | | | | | | | Revenue by format | | | | | | | | | | | | | Electronic | | 3,320 | | 2,618 | | 1,707 | | 83 | | - | | 7,728 | Face-to-face | | 16 | | 6 | | 11 | | 1,156 | | - | | 1,189 | Print | | - | | - | | - | | - | | 517 | | 517 | Total revenue | | 3,336 | | 2,624 | | 1,718 | | 1,239 | | 517 | | 9,434 | | | | | | | | | | | | | | Revenue by type | | | | | | | | | | | | | Subscriptions | | 1,329 | | 2,110 | | 1,432 | | - | | 154 | | 5,025 | Transactional | | 2,007 | | 514 | | 286 | | 1,239 | | 363 | | 4,409 | Total revenue | | 3,336 | | 2,624 | | 1,718 | | 1,239 | | 517 | | 9,434 |
| | | | | | | | | | | | | 2025 | | Risk GBPm | | Scientific, Technical & Medical GBPm | | Legal GBPm | | Exhibitions GBPm | | Print & print- related activities GBPm | | Total GBPm | Revenue by geographical market | | | | | | | | | | | | | North America | | 2,749 | | 1,161 | | 1,229 | | 237 | | 219 | | 5,595 | Europe* | | 469 | | 619 | | 391 | | 424 | | 97 | | 2,000 | Rest of world | | 267 | | 934 | | 186 | | 525 | | 83 | | 1,995 | Total revenue | | 3,485 | | 2,714 | | 1,806 | | 1,186 | | 399 | | 9,590 | | | | | | | | | | | | | | Revenue by format | | | | | | | | | | | | | Electronic | | 3,475 | | 2,707 | | 1,794 | | 94 | | - | | 8,070 | Face-to-face | | 10 | | 7 | | 12 | | 1,092 | | - | | 1,121 | Print | | - | | - | | - | | - | | 399 | | 399 | Total revenue | | 3,485 | | 2,714 | | 1,806 | | 1,186 | | 399 | | 9,590 | | | | | | | | | | | | | | Revenue by type | | | | | | | | | | | | | Subscriptions | | 1,363 | | 2,168 | | 1,527 | | - | | 132 | | 5,190 | Transactional | | 2,122 | | 546 | | 279 | | 1,186 | | 267 | | 4,400 | Total revenue | | 3,485 | | 2,714 | | 1,806 | | 1,186 | | 399 | | 9,590 |
* | Europe includes revenue of £634m from the United Kingdom (2024: £613m; 2023: £602m). |
Over half of RELX’s revenue comes from subscription arrangements, and revenue for these is generally recognised on a straight-line basis over the time period covered by the agreement, in line with the provision of services. There are a number of multi-year contracts, mainly in Risk, where revenue is recognised on the achievement of delivery milestones or other specified performance obligations. As at 31 December 2025, the aggregate amount of the transaction price of such contracts which relates to performance obligations which have not yet been delivered was approximately £35m (2024: £55m). It is expected that revenue will be recognised in relation to this amount over the next two years. | | | | | | | ANALYSIS OF REVENUE BY GEOGRAPHICAL ORIGIN | | 2023 GBPm | | 2024 GBPm | | 2025 GBPm | North America | | 5,325 | | 5,461 | | 5,551 | Europe | | 3,117 | | 3,270 | | 3,305 | Rest of world | | 719 | | 703 | | 734 | Total | | 9,161 | | 9,434 | | 9,590 |
Revenue by geographical origin from the United Kingdom in 2025 was £1,836m (2024: £1,789m; 2023: £1,703m). 2 Revenue, operating profit and segment analysis (continued) | | | | | | | | | | | | | | | | | | | | | | | | | ANALYSIS BY REPORTED SEGMENT | | Expenditure on acquired goodwill and intangible assets | | Capital expenditure additions | | Amortisation of acquired intangible assets | | Total depreciation and other amortisation | | | Restated 2023 GBPm | | Restated 2024 GBPm | | 2025 GBPm | | Restated 2023 GBPm | | Restated 2024 GBPm | | 2025 GBPm | | Restated 2023 GBPm | | Restated 2024 GBPm | | 2025 GBPm | | Restated 2023 GBPm | | Restated 2024 GBPm | | 2025 GBPm | Risk | | 79 | | - | | 249 | | 139 | | 148 | | 156 | | 194 | | 184 | | 175 | | 92 | | 99 | | 102 | Scientific, Technical & Medical | | 3 | | 8 | | 5 | | 107 | | 103 | | 116 | | 59 | | 44 | | 39 | | 133 | | 123 | | 124 | Legal | | 42 | | 145 | | - | | 193 | | 203 | | 225 | | 11 | | 15 | | 20 | | 242 | | 252 | | 239 | Exhibitions | | 8 | | 65 | | 20 | | 37 | | 29 | | 27 | | 16 | | 15 | | 14 | | 39 | | 45 | | 34 | Print & print-related activities | | - | | - | | - | | 1 | | 1 | | 1 | | - | | - | | - | | 8 | | 6 | | 5 | Total | | 132 | | 218 | | 274 | | 477 | | 484 | | 525 | | 280 | | 258 | | 248 | | 514 | | 525 | | 504 |
Capital expenditure comprises additions to property, plant and equipment and internally developed intangible assets. Depreciation and other amortisation includes depreciation on property, plant and equipment and right-of-use assets and amortisation of internally developed intangible assets and pre-publication costs. | | | | | | | ANALYSIS OF NON-CURRENT ASSETS BY GEOGRAPHICAL LOCATION | | | | 2024 GBPm | | 2025 GBPm | North America | | | | 9,131 | | 8,545 | Europe | | | | 2,259 | | 2,459 | Rest of world | | | | 438 | | 459 | Total | | | | 11,828 | | 11,463 |
Non-current assets held in the United Kingdom totalled £1,503m (2024: £1,242m; 2023: £1,209m). Non-current assets by geographical location exclude amounts relating to deferred tax, pension assets and derivative financial instruments. Operating profit is reconciled to adjusted operating profit as follows: | | | | | | | RECONCILIATION OF OPERATING PROFIT TO ADJUSTED OPERATING PROFIT | | 2023 GBPm | | 2024 GBPm | | 2025 GBPm | Operating profit | | 2,682 | | 2,861 | | 3,027 | Adjustments: | | | | | | | Amortisation of acquired intangible assets | | 280 | | 258 | | 248 | Acquisition and disposal related items | | 56 | | 69 | | 54 | Reclassification of tax in joint ventures and associates | | 12 | | 12 | | 14 | Reclassification of finance income in joint ventures and associates | | - | | (1) | | (1) | Adjusted operating profit | | 3,030 | | 3,199 | | 3,342 |
|